Is Real-world Evidence Really Real?

REFERENCES

1. 1.↵
   1. Glasziou P,
   2. Vandenbroucke JP,
   3. Chalmers I.

   Assessing the quality of research. BMJ 2004;328:39-41.

   OpenUrlFREE Full Text
2. 2.↵
   1. Vandenbroucke JP,
   2. von Elm E,
   3. Altman DG, et al; STROBE Initiative

   . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007;147:W163-94.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Griffiths H,
   2. Smith T,
   3. Mack C, et al.

   Persistence to biologic therapy among patients with ankylosing spondylitis: an observational study using the OPAL dataset. J Rheumatol 2022;49:150–6

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Acar M,
   2. Juneja P,
   3. Handel M.

   Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD). Open Access Rheumatol 2018; 10:151-60.

   OpenUrl